Thursday, March 29, 2012

Webinar to Review Results of Opioid Addiction Treatment Study

The Physicians’ Clinical Support System-Buprenorphine (PCSS-B) will present a webinar on April 10 from noon to 1:00 p.m. (EST) titled "The Use of Buprenorphine in the Treatment of Prescription Opioid Dependence." The webinar will be given by Roger Weiss, M.D., a professor of psychiatry at Harvard University and chief of the Chief, Alcohol and Drug Abuse Treatment Program at McLean Hospital.

This webinar will review results of the Prescription Opioid Addiction Treatment Study (POATS), the first large-scale treatment study for patients dependent on prescription opioids. POATS, which was conducted under the auspices of the National Institute on Drug Abuse Clinical Trials Network, studied combinations of different lengths of buprenorphine and different intensities of counseling to treat 653 patients dependent on prescription opioids. The presentation will review the design of the study, the main outcomes, and the role of chronic pain and a history of heroin use as prognostic factors. The PCSS-B is operated by the American Academy of Addiction Psychiatry, the American Osteopathic Academy of Addiction Medicine, and APA with funding from the Substance Abuse and Mental Health Services Administration/Center for Substance Abuse Treatment.

Register for the webinar here, and visit for a variety of clinical resources, including recordings of previous webinars.

(Image: PCSS-B)


The content of Psychiatric News does not necessarily reflect the views of APA or the editors. Unless so stated, neither Psychiatric News nor APA guarantees, warrants, or endorses information or advertising in this newspaper. Clinical opinions are not peer reviewed and thus should be independently verified.